knowledge -WSS

knowledge

author：explore 2025-09-30 00:36:23 - browse：4583

In this photo illustration, Farxiga, Xarelto, Entresto, and Eliquis are made available to customers at the New City Halsted Pharmacy on August 29, 2023 in Chicago, Illinois. These are 4 of 10 prescription drugs that will be subject to Medicare price negotiations under the Inflation Reduction Act. The other drugs include Jardiance, Enbrel, Januvia, Imbruvica, Stelara and Fiasp. — Scott Olson/Getty Images

WASHINGTON — The Biden administration is making its opening offers to pharmaceutical companies in its brand-new Medicare drug price negotiation program on Thursday, administration officials said. And that’s about all they said.

The offers will not be made public unless a manufacturer chooses to publicly disclose information about the talks, a senior administration official said. Companies have until March 2 to either accept the government’s offer or propose a counteroffer. The Biden administration will publish the final prices by Sept. 1 of this year after the negotiation process ends.

The negotiated prices won’t take effect until 2026.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban
Next article： STAT Virtual Event: ASCO Recap, Live!

hotspot

entertainment

WSS

New report analyzes digital physical therapy solutions' effectiveness

FDA scientists endorse Pfizer/BioNTech Covid

CDC recommends RSV monoclonal antibody for infants

Statins may not be needed by millions of people, study suggests

The cancer stories no one wants to hear

H.R. 3 is the wrong path to lower drug costs

entertainment

knowledge

hotspot

Trump demands the U.S. pay no more for drugs than other countries … again

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

FDA approval of Sarepta Duchenne genetic therapy gives me hope

'Essentially witchcraft:' A former naturopath takes on the field

At least 13 dead in Texas as scorching temps continue

Cheap, fast test for Zika and dengue could cost just $1

United colonoscopy coverage change 'may cost lives,' doctors say

Group behind ProMed defends move to subscription

Jerome Adams on the need for new antivirals for Covid

Flint parents haunted by uncertainty, fears of lead poisoning

Wikipedia

Health care court cases: Humana, Sutter, Novant

How to ethically and practically extend health care to all

Study links childhood stress with decline in older age

Statins may not be needed by millions of people, study suggests

The a glaring gap in research on serious mental illness and primary care

The cancer stories no one wants to hear

knowledge

hotspot

entertainment

knowledge